The Food and Drug Administration is expanding approval of leucovorin to treat an ultra-rare genetic condition.
The FDA officials also pointed out that one study supporting the generic drug’s use for autism was retracted earlier this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results